{
    "organizations": [],
    "uuid": "6bd86aba71b4c54261a538e511eec31012c4de23",
    "author": "Reuters Editorial",
    "url": "https://www.reuters.com/article/brief-eyegate-gets-milestone-payment-for/brief-eyegate-gets-milestone-payment-for-confirmatory-study-of-eye-inflammation-treatment-idUSASC09V4Y",
    "ord_in_thread": 0,
    "title": "BRIEF-EyeGate Gets Milestone Payment For Confirmatory Study Of Eye Inflammation Treatment",
    "locations": [],
    "highlightText": "",
    "language": "english",
    "persons": [],
    "text": "April 6 (Reuters) - EyeGate Pharmaceuticals Inc:\n* EYEGATE COMPLETES ENROLLMENT AND RECEIVES MILESTONE PAYMENT FOR CONFIRMATORY PHASE 3 CLINICAL STUDY OF EGP-437 IN ANTERIOR UVEITIS Source text for Eikon: Further company coverage:\n ",
    "published": "2018-04-06T20:50:00.000+03:00",
    "crawled": "2018-04-07T16:19:11.000+03:00",
    "highlightTitle": "",
    "preprocessed_text": [
        "april",
        "reuters",
        "eyegate",
        "pharmaceutical",
        "inc",
        "eyegate",
        "completes",
        "enrollment",
        "receives",
        "milestone",
        "payment",
        "confirmatory",
        "phase",
        "clinical",
        "study",
        "anterior",
        "uveitis",
        "source",
        "text",
        "eikon",
        "company",
        "coverage"
    ]
}